MedPath

TEVA-ACYCLOVIR

TEVA-ACYCLOVIR

Approved
DIN Number

02285975

Drug Class

Human

Market Date

Oct 23, 2006

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02285975
AIG Number0115506005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AB01 ACYCLOVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

ACYCLOVIRActive
Strength: 800 MG
Monograph: ACYCLOVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.